Adjuvant interferon treatment for melanoma

被引：25

作者：

Agarwala, SS ^{[1
]}

Kirkwood, JM ^{[1
]}

机构：

[1] Univ Pittsburgh, Ctr Hlth, Pittsburgh, PA USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1998年 / 12卷 / 04期

关键词：

D O I：

10.1016/S0889-8588(05)70025-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This article summarizes recent and ongoing efforts in the area of adjuvant interferon treatment for cutaneous melanoma. Interferon therapy targets the immune system in an attempt to cure high-risk melanoma. More than a decade of interferon research has culminated in the successful application of interferon-alpha-2b in melanoma, with significantly prolonged survival in patients at high risk for recurrence after surgical resection.

引用

页码：823 / +

页数：12

共 24 条

[1] PROGNOSIS IN SMALL CELL-CARCINOMA OF THE LUNG - RELATIONSHIP TO HUMAN-MILK FAT GLOBULE-2 (HMFG2) ANTIGEN AND OTHER SMALL-CELL ASSOCIATED ANTIGENS
ALLAN, SG
HAY, FG
MCINTYRE, MA
LEONARD, RCF
[J]. BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 485 - 488
[2] BOON T, 1992, CANCER SURV, V13, P23
[3] Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system
Buzaid, AC
Ross, MI
Balch, CM
Soong, SJ
McCarthy, WH
Tinoco, L
Mansfield, P
Lee, JE
Bedikian, A
Eton, O
Plager, C
Papadopoulos, N
Legha, SS
Benjamin, RS
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1039 - 1051
[4] RESULTS OF ADJUVANT INTERFERON STUDY IN WHO MELANOMA PROGRAM
CASCINELLI, N
BUFALINO, R
MORABITO, A
MACKIE, R
[J]. LANCET, 1994, 343 (8902) : 913 - 914
[5] CASCINELLI N, 1995, P AM ASS CLIN ONCOL, V14, P1296
[6] Quality-of-life - adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group Study
Cole, BF
Gelber, RD
Kirkwood, JM
Goldhirsch, A
Barylak, E
Borden, E
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2666 - 2673
[7] Coulie Pierre G., 1993, Current Opinion in Oncology, V5, P1043, DOI 10.1097/00001622-199311000-00016
[8] RANDOMIZED, SURGICAL ADJUVANT CLINICAL-TRIAL OF RECOMBINANT INTERFERON ALFA-2A IN SELECTED PATIENTS WITH MALIGNANT-MELANOMA
CREAGAN, ET
DALTON, RJ
AHMANN, DL
JUNG, SH
MORTON, RF
LANGDON, RM
KUGLER, J
RODRIGUE, LJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) : 2776 - 2783
[9] COSTS AND BENEFITS OF ADJUVANT THERAPY IN BREAST-CANCER - A QUALITY-ADJUSTED SURVIVAL ANALYSIS
GOLDHIRSCH, A
GELBER, RD
SIMES, RJ
GLASZIOU, P
COATES, AS
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 36 - 44
[10] Grob J. J., 1997, Melanoma Research, V7, pS33

← 1 2 3 →